NVIV up 40%+ today. Geron (GERN) down down down. Relationship: Geron dropped its embryonic stem cell program for acute spinal injury patients just after Dr. Wirther, a regenerative medicine pioneer moved to NVIV to lead soon to be new trials in spinal cord scaffolding for similarly injured patients. Hmmm... Spot-long GERN and NVIV (I liked Orwellian better too).
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat